Live Breaking News & Updates on Vaccines announce european partnership for marketing

VALNEVA: Valneva Reports Full Year 2022 Results and Provides Corporate Updates

Total revenues of €361.3 million in 2022 compared to €348.1 million in 2021 Driven by product sales of €114.8 million (82.3% increase compared to 2021), including €85.2 million of travel vaccine sales

Japan , Finland , Australia , Thailand , France , New-zealand , Sweden , United-kingdom , United-arab-emirates , Denmark , Austria , Germany